Feng W - Search Results

1

Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.

Peng Z, Xiao Z, Wang Y, Liu P, Cai Y, Lu S, Feng W, Han ZC. Peng Z, et al. Among authors: feng w. Cancer Gene Ther. 2004 Nov;11(11):707-12. doi: 10.1038/sj.cgt.7700738. Cancer Gene Ther. 2004. PMID: 15375375

2

Purification of TAT-CC-HA protein under native condition, and its transduction analysis and biological effects on BCR-ABL positive cells.

Huang Z, Ji M, Peng Z, Huang S, Xiao Q, Li C, Zeng J, Gao M, Feng W. Huang Z, et al. Among authors: feng w. Biomed Pharmacother. 2011 Jun;65(3):183-92. doi: 10.1016/j.biopha.2011.02.013. Epub 2011 May 20. Biomed Pharmacother. 2011. PMID: 21641753

3

Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides.

Yang H, Zhou H, Huang Z, Tao K, Huang N, Peng Z, Feng W. Yang H, et al. Among authors: feng w. Cancer Lett. 2020 Jul 10;482:44-55. doi: 10.1016/j.canlet.2020.04.010. Epub 2020 Apr 10. Cancer Lett. 2020. PMID: 32278814

4

Targeted blockage of signal transducer and activator of transcription 5 signaling pathway with decoy oligodeoxynucleotides suppresses leukemic K562 cell growth.

Wang X, Zeng J, Shi M, Zhao S, Bai W, Cao W, Tu Z, Huang Z, Feng W. Wang X, et al. Among authors: feng w. DNA Cell Biol. 2011 Feb;30(2):71-8. doi: 10.1089/dna.2010.1112. Epub 2010 Nov 22. DNA Cell Biol. 2011. PMID: 21091189 Free PMC article.

5

miR-29b suppresses CML cell proliferation and induces apoptosis via regulation of BCR/ABL1 protein.

Li Y, Wang H, Tao K, Xiao Q, Huang Z, Zhong L, Cao W, Wen J, Feng W. Li Y, et al. Among authors: feng w. Exp Cell Res. 2013 May 1;319(8):1094-101. doi: 10.1016/j.yexcr.2013.02.002. Epub 2013 Feb 18. Exp Cell Res. 2013. PMID: 23428668

6

Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate.

Li Y, Yuan Y, Tao K, Wang X, Xiao Q, Huang Z, Zhong L, Cao W, Wen J, Feng W. Li Y, et al. Among authors: feng w. PLoS One. 2013 Apr 16;8(4):e61858. doi: 10.1371/journal.pone.0061858. Print 2013. PLoS One. 2013. PMID: 23613955 Free PMC article.

7

MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis.

Zu B, Li Y, Wang X, He D, Huang Z, Feng W. Zu B, et al. Among authors: feng w. Pharmacogenomics. 2014 Apr;15(5):667-77. doi: 10.2217/pgs.13.222. Pharmacogenomics. 2014. PMID: 24798723

8

ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell.

Liu X, Li Y, Wen L, Tao K, Xiao Q, Cao W, Huang Z, Gao M, Li H, Wang F, Feng W. Liu X, et al. Among authors: feng w. Cancer Lett. 2015 Dec 1;369(1):222-8. doi: 10.1016/j.canlet.2015.08.017. Epub 2015 Aug 28. Cancer Lett. 2015. PMID: 26321052

9

Efficient disruption of bcr-abl gene by CRISPR RNA-guided FokI nucleases depresses the oncogenesis of chronic myeloid leukemia cells.

Luo Z, Gao M, Huang N, Wang X, Yang Z, Yang H, Huang Z, Feng W. Luo Z, et al. Among authors: feng w. J Exp Clin Cancer Res. 2019 May 28;38(1):224. doi: 10.1186/s13046-019-1229-5. J Exp Clin Cancer Res. 2019. PMID: 31138265 Free PMC article.

10

Inhibition of KPNB1 Inhibits Proliferation and Promotes Apoptosis of Chronic Myeloid Leukemia Cells Through Regulation of E2F1.

Wang T, Huang Z, Huang N, Peng Y, Gao M, Wang X, Feng W. Wang T, et al. Among authors: feng w. Onco Targets Ther. 2019 Dec 2;12:10455-10467. doi: 10.2147/OTT.S210048. eCollection 2019. Onco Targets Ther. 2019. PMID: 31819526 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,092 results

Search Page

Filters